TWAS-CTL: A robust and efficient method for multi-tissue transcriptome-wide association studies using cross-tissue learners

preprint OA: closed
📄 Open PDF Full text JSON View at publisher

Abstract

The advent of transcriptome-wide association studies (TWAS) has expanded the classical genome-wide association study (GWAS) framework by integrating gene expression with genetic variation to identify trait-associated variants. While multi-tissue TWAS approaches improve statistical power over single-tissue models, existing methods often lose information during result aggregation and require intensive computation. Here, we present TWAS-CTL (Cross-Tissue Learner), a novel framework that leverages heterogeneous gene expression across tissues by adaptively reweighting and optimizing multiple single-tissue learners. Simulations demonstrate that TWAS-CTL achieves higher statistical power than the leading method, UTMOST, while maintaining proper type I error control and reducing computational time by over half. When applied to the analysis of the Genetics of Kidneys in Diabetes (GoKinD) cohort, we observed that TWAS-CTL identified more susceptible genes associated with diabetes than both UTMOST and PrediXcan, another widely used method in TWAS. These results establish TWAS-CTL as a powerful and efficient tool for cross-tissue gene expression analysis, capable of integrating heterogeneous gene-trait associations to advance genetic discovery.
Full text 1,647 characters · extracted from oa-doi-fallback · click to expand
Abstract The advent of transcriptome-wide association studies (TWAS) has expanded the classical genome-wide association study (GWAS) framework by integrating gene expression with genetic variation to identify trait-associated variants. While multi-tissue TWAS approaches improve statistical power over single-tissue models, existing methods often lose information during result aggregation and require intensive computation. Here, we present TWAS-CTL (Cross-Tissue Learner), a novel framework that leverages heterogeneous gene expression across tissues by adaptively reweighting and optimizing multiple single-tissue learners. Simulations demonstrate that TWAS-CTL achieves higher statistical power than the leading method, UTMOST, while maintaining proper type I error control and reducing computational time by over half. When applied to the analysis of the Genetics of Kidneys in Diabetes (GoKinD) cohort, we observed that TWAS-CTL identified more susceptible genes associated with diabetes than both UTMOST and PrediXcan, another widely used method in TWAS. These results establish TWAS-CTL as a powerful and efficient tool for cross-tissue gene expression analysis, capable of integrating heterogeneous gene-trait associations to advance genetic discovery. Competing Interest Statement The authors have declared no competing interest. Footnotes Changes from previous version- fixed typos, further refined all the sections (Introduction, Methods, Results, Discussion), etc. https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000424.v8.p2 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000018.v2.p1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00